A previous study has shown that inhibition of Ezh2 methyltransferase activity can inhibit tumor cells in an Arid1a-mutated model, highlighting the antagonism of Ezh2 and Arid1a in tumor formation. This evidence concerns the gene ARID1A and neoplasm.